Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
This article reviews the Q4 earnings of several biotechnology stocks, highlighting Incyte’s performance against its peers. It discusses the high-risk, high-reward nature of the biotechnology industry and details the Q4 results for Incyte, Novavax, United Therapeutics, BioMarin Pharmaceutical, and Moderna, including revenue figures, analyst beats/misses, and stock performance. The article also provides a brief market update on shifting investor concerns related to AI and geopolitical risks.